ArticleFrontiers in oncology2026
Unlocking radiotherapy access: the critical role of structural quality and radiation therapists in Saudi Arabia.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objective: Access to radiotherapy (RT) remains a challenge even in high-income countries such as the Kingdom of Saudi Arabia (KSA). This study aims to examine how key structural indicators such as staffing and equipment availability, distribution, and capacity affect access to care and the quality of RT services in Saudi Arabia. Methods: A mixed-methods design using a descriptive cross-sectional approach was employed. A survey was distributed electronically to supervisors and managers of 20 RT units in the KSA between September 24 and October 23, 2025. The qualitative phase explored the perspectives of radiation therapists (RTTs) and medical physicists, whereas the quantitative phase examined variables such as staff numbers and distribution, patient volumes, equipment availability, treatment waiting times, and overall facility capacity between January and December 2024. Results: The survey response rate was 85% (n =20). Public facilities treated the highest caseloads but had fewer linear accelerators per patient, higher clinician workloads, and longer waiting times, with radical treatment often exceeding 14 days and, in some cases, extending beyond 42 days. The mixed centers had the highest machine capacity and advanced technologies. Training opportunities were limited, particularly in the public sector, where most departments rated staffing and operational efficiency inadequate. Equipment procurement presented a challenge with 65% of centers (majority in the public sector), expressing tendering delays severely or critically affected their ability to provide care. Conclusion: These findings support the development of a strategic framework to strengthen RT capacity and reduce sector-based disparities. Outsourcing initiatives among different facility types have already been initiated. Ultimately, these results may support policy development and resource planning to promote more equitable cancer care delivery in the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.